BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou C, Pan R, Li B, Huang T, Zhao J, Ying J, Duan S. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60. Future Oncol 2019;15:1279-89. [PMID: 30924352 DOI: 10.2217/fon-2018-0674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Meng G, Yang C, Li H, Liu L, Wu Y, Liu B. Changes in epigenetic information during the occurrence and development of gastric cancer. The International Journal of Biochemistry & Cell Biology 2022;153:106315. [DOI: 10.1016/j.biocel.2022.106315] [Reference Citation Analysis]
2 Fang H, Li H, Zhang H, Wang S, Xu S, Chang L, Yang Y, Cui R. Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers. Front Pharmacol 2022;13:1019312. [DOI: 10.3389/fphar.2022.1019312] [Reference Citation Analysis]
3 Zhou R, Peng N, Li W. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma. Front Immunol 2022;13:964919. [DOI: 10.3389/fimmu.2022.964919] [Reference Citation Analysis]
4 Wei C, Li M, Lin S, Xiao J, Parameshachari BD. Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. BioMed Research International 2022;2022:1-27. [DOI: 10.1155/2022/4006507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Hao X, Li Y, Bian J, Zhang Y, He S, Yu F, Feng Y, Huang L. Impact of DNA methylation on ADME gene expression, drug disposition and efficacy. Drug Metab Rev 2022;:1-22. [PMID: 35412942 DOI: 10.1080/03602532.2022.2064488] [Reference Citation Analysis]
6 Xie J, Fu L, Zhang J, Pandurangan A. Analysis of Influencing Factors on the Occurrence and Development of Gastric Cancer in High-Incidence Areas of Digestive Tract Tumors Based on High Methylation of GPX3 Gene. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/3094881] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Yin HM, He Q, Chen J, Li Z, Yang W, Hu X. Drug metabolism-related eight-gene signature can predict the prognosis of gastric adenocarcinoma. J Clin Lab Anal 2021;35:e24085. [PMID: 34773716 DOI: 10.1002/jcla.24085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Tian S, Zhao S, Tang M, Wang C. Gene expression barcode values reveal a potential link between Parkinson's disease and gastric cancer. Aging (Albany NY) 2021;13:6171-81. [PMID: 33596182 DOI: 10.18632/aging.202623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tang J, Pan R, Xu L, Ma Q, Ying X, Zhao J, Zhao H, Miao L, Xu Y, Duan S, Wang J. IL10 hypomethylation is associated with the risk of gastric cancer. Oncol Lett 2021;21:241. [PMID: 33664805 DOI: 10.3892/ol.2021.12502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
10 Chen H, Xu L, Shan ZL, Chen S, Hu H. GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway. Cancer Cell Int 2020;20:596. [PMID: 33317536 DOI: 10.1186/s12935-020-01692-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
11 Lee H, Ismail T, Kim Y, Chae S, Ryu HY, Lee DS, Kwon TK, Park TJ, Kwon T, Lee HS. Xenopus gpx3 Mediates Posterior Development by Regulating Cell Death during Embryogenesis. Antioxidants (Basel) 2020;9:E1265. [PMID: 33322741 DOI: 10.3390/antiox9121265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Nirgude S, Choudhary B. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem Pharmacol 2021;184:114365. [PMID: 33310051 DOI: 10.1016/j.bcp.2020.114365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
13 Yang S, Gao T, Zheng Z, Lai B, Sheng L, Xu Z, Yan X, Wang J, Duan S, Ouyang G. GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da. J Int Med Res 2020;48:300060520956894. [PMID: 32967500 DOI: 10.1177/0300060520956894] [Reference Citation Analysis]
14 Zhang ML, Wu HT, Chen WJ, Xu Y, Ye QQ, Shen JX, Liu J. Involvement of glutathione peroxidases in the occurrence and development of breast cancers. J Transl Med 2020;18:247. [PMID: 32571353 DOI: 10.1186/s12967-020-02420-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
15 Wei J, Xie Q, Liu X, Wan C, Wu W, Fang K, Yao Y, Cheng P, Deng D, Liu Z. Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia. Ann Transl Med 2020;8:678. [PMID: 32617298 DOI: 10.21037/atm-20-3296] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
16 Zhang X, Zhan D, Li Y, Wang H, Cheng C, Yao Y, Jia J. Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data. Med Sci Monit 2020;26:e921775. [PMID: 32392186 DOI: 10.12659/MSM.921775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lin Y, Zhang Y, Chen Y, Liu Z. Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma. Pathology - Research and Practice 2019;215:152676. [DOI: 10.1016/j.prp.2019.152676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]